185 related articles for article (PubMed ID: 36346561)
1. Thioredoxin-Interacting Protein Inhibited Vascular Endothelial Cell-Induced HREC Angiogenesis Treatment of Diabetic Retinopathy.
Yan J; Deng J; Cheng F; Zhang T; Deng Y; Cai Y; Cong W
Appl Biochem Biotechnol; 2023 Feb; 195(2):1268-1283. PubMed ID: 36346561
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
Duan J; Du C; Shi Y; Liu D; Ma J
Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of ChREBP ameliorates retinal microvascular endothelial cell injury and angiogenic responses in diabetic retinopathy.
Sui Y; Du C; Wang M; Liu X; Chai Q; Liang S; Ma J; Duan J
Biochem Biophys Res Commun; 2024 Jan; 694():149389. PubMed ID: 38128383
[TBL] [Abstract][Full Text] [Related]
4. Deletion of thioredoxin interacting protein (TXNIP) augments hyperoxia-induced vaso-obliteration in a mouse model of oxygen induced-retinopathy.
Abdelsaid MA; Matragoon S; Ergul A; El-Remessy AB
PLoS One; 2014; 9(10):e110388. PubMed ID: 25329456
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin-interacting protein expression is required for VEGF-mediated angiogenic signal in endothelial cells.
Abdelsaid MA; Matragoon S; El-Remessy AB
Antioxid Redox Signal; 2013 Dec; 19(18):2199-212. PubMed ID: 23718729
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
[TBL] [Abstract][Full Text] [Related]
7. A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesis.
Dunn LL; Simpson PJ; Prosser HC; Lecce L; Yuen GS; Buckle A; Sieveking DP; Vanags LZ; Lim PR; Chow RW; Lam YT; Clayton Z; Bao S; Davies MJ; Stadler N; Celermajer DS; Stocker R; Bursill CA; Cooke JP; Ng MK
Diabetes; 2014 Feb; 63(2):675-87. PubMed ID: 24198286
[TBL] [Abstract][Full Text] [Related]
8. A prodrug of epigallocatechin-3-gallate alleviates high glucose-induced pro-angiogenic factor production by inhibiting the ROS/TXNIP/NLRP3 inflammasome axis in retinal Müller cells.
Du J; Wang Y; Tu Y; Guo Y; Sun X; Xu X; Liu X; Wang L; Qin X; Zhu M; Song E
Exp Eye Res; 2020 Jul; 196():108065. PubMed ID: 32407725
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of thioredoxin interacting protein in Müller cells attenuates photoreceptor apoptosis in streptozotocin-induced diabetic mouse model.
Li N; Gao S; Gao S; Wang Y; Huang H; Wang J; Shen X
Int J Biol Macromol; 2024 Jun; 271(Pt 2):132731. PubMed ID: 38815945
[TBL] [Abstract][Full Text] [Related]
10. YAP/TAZ Signaling Enhances Angiogenesis of Retinal Microvascular Endothelial Cells in a High-Glucose Environment.
Wang XL; Xian Y; Chen XL
Curr Eye Res; 2024 May; 49(5):524-532. PubMed ID: 38305219
[TBL] [Abstract][Full Text] [Related]
11. MiR-20b targets AKT3 and modulates vascular endothelial growth factor-mediated changes in diabetic retinopathy.
Qin B; Liu J; Liu S; Li B; Ren J
Acta Biochim Biophys Sin (Shanghai); 2016 Aug; 48(8):732-40. PubMed ID: 27421659
[TBL] [Abstract][Full Text] [Related]
12. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
[TBL] [Abstract][Full Text] [Related]
13. Berberine improves insulin-induced diabetic retinopathy through exclusively suppressing Akt/mTOR-mediated HIF-1α/VEGF activation in retina endothelial cells.
Wang N; Zhang C; Xu Y; Tan HY; Chen H; Feng Y
Int J Biol Sci; 2021; 17(15):4316-4326. PubMed ID: 34803500
[No Abstract] [Full Text] [Related]
14. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
Wang L; Liu WX; Huang XG
Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
[TBL] [Abstract][Full Text] [Related]
15. LECT2 Ameliorates Blood-Retinal Barrier Impairment Secondary to Diabetes Via Activation of the Tie2/Akt/mTOR Signaling Pathway.
Qin YJ; Xiao K; Zhong Z; Zhao Y; Yu T; Sun XF
Invest Ophthalmol Vis Sci; 2022 Mar; 63(3):7. PubMed ID: 35262733
[TBL] [Abstract][Full Text] [Related]
16. Protection of leukemia inhibitory factor against high-glucose-induced human retinal endothelial cell dysfunction.
Wang L; Wu Q; Wang RQ; Wang RZ; Wang J
Arch Physiol Biochem; 2023 Feb; 129(1):33-40. PubMed ID: 32658632
[TBL] [Abstract][Full Text] [Related]
17. Gαi1/3 mediate Netrin-1-CD146-activated signaling and angiogenesis.
Li Y; Chai JL; Shi X; Feng Y; Li JJ; Zhou LN; Cao C; Li KR
Theranostics; 2023; 13(7):2319-2336. PubMed ID: 37153740
[TBL] [Abstract][Full Text] [Related]
18. The mechanism of EGFL7 regulating neovascularization in diabetic retinopathy through the PI3K/AKT/VEGFA pathway.
Xian Y; Wang X; Yu Y; Chen X
Life Sci; 2024 Mar; 340():122483. PubMed ID: 38307238
[TBL] [Abstract][Full Text] [Related]
19. Capilliposide B blocks VEGF-induced angiogenesis in vitro in primary human retinal microvascular endothelial cells.
Han H; Yang Y; Wu Z; Liu B; Dong L; Deng H; Tian J; Lei H
Biomed Pharmacother; 2021 Jan; 133():110999. PubMed ID: 33227710
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin-interacting protein mediates sustained VEGFR2 signaling in endothelial cells required for angiogenesis.
Park SY; Shi X; Pang J; Yan C; Berk BC
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):737-43. PubMed ID: 23393387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
